Financials

%ChgLast 12MReverse

	FY202312/31/2023	FY202412/31/2024	FY202512/31/2025	Last 12M03/31/2026
Cash and Cash Equivalents	39.2	30.3	7.7	1.8
Short Term Investments	-	-	-	-
Cash and Short Term Investments	39.2	30.3	7.7	1.8
Net Receivables	-	-	-	-
Inventory	-	-	-	-
Other Current Assets	0.1	0.5	0.4	0.0
Total Current Assets	40.4	31.5	8.3	2.4
Property, Plant & Equipment	10.8	9.5	8.1	7.8
Long Term Investments	-	0.4	-	-
Other Non-Current Assets	0.4	0.1	0.5	0.5
Total Non-Current Assets	11.2	10.0	8.7	8.3
Total Assets	51.6	41.5	16.9	10.7
Account Payables	0.8	2.5	1.0	0.6
Short Term Debt	4.3	6.4	-	-
Deferred Revenue	-	-	-	-
Other Current Liabilities	1.8	-	0.1	0.3
Total Current Liabilities	9.4	14.2	3.3	3.3
Long Term Debt	6.3	-	6.9	6.6
Other Non-Current Liabilities	-	-	-	-
Total Non-Current Liabilities	15.4	8.1	6.9	6.6
Total Liabilities	24.8	22.4	10.3	9.9
Common Stock	0.0	0.0	0.0	0.0
Retained Earnings	-165.3	-207.1	-233.4	-270.1
Total Stockholders Equity	26.8	19.1	6.7	0.8
Total Liabilities and Equity	51.6	41.5	16.9	10.7

Tempest Therapeutics, Inc.(TPST US)